A 77-1726

CAS: 163451-81-8

Ref. TR-A771726

Produktinformation

• Name: A 77-1726
• Synonyme: (2Z)-2-cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-Butenamide, 2-Butenamide, 2-cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-, (Z)-, A 1726, A 771726, Aubagio, Flucyamide, HMR 1726, SU 20, Teriflunomide,(2Z)-2-Cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]but-2-enamide
• Marke: TRC
• Beschreibung: Impurity Leflunomide EP Impurity BApplications A77 1726 (Leflunomide EP Impurity B) is the active metabolite of Leflunomide, a potent disease-modifying antirheumatic drug used in the treatment of rheumatoid arthritis. LEF-M interferes with dendritic cell function. The second Phase III study evaluating the efficacy of Genzyme’s teriflunomide therapy against relapsing forms of multiple sclerosis found the once-daily oral drug to be no less effective than injectable interferon beta 1a (Rebif®).References Kirsch, B.M., et al.: Arthritis Research and Therapy, 7, 3, R694, (2005)

Chemische Eigenschaften

• Molekulargewicht: 270.21
• Formel: C₁₂H₉F₃N₂O₂
• Farbe/Form: White To Off-White
• InChl: InChI=1S/C12H9F3N2O2/c1-7(18)10(6-16)11(19)17-9-4-2-8(3-5-9)12(13,14)15/h2-5,18H,1H3,(H,17,19)/b10-7-
• SMILES: C/C(O)=C(\C#N)C(=O)Nc1ccc(C(F)(F)F)cc1